We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
3376
Arrowhead Research
ARWR
$12.4B
$2K ﹤0.01%
100
-1,473
-94% -$24.3K
AXGN icon
3377
Axogen
AXGN
$2.5B
$2K ﹤0.01%
+109
New +$1.99K
AXR icon
3378
AMREP Corp
AXR
$119M
$2K ﹤0.01%
333
-82
-20% -$499
BANF icon
3379
BancFirst
BANF
$3.8B
$2K ﹤0.01%
42
-159
-79% -$8.61K
BFST icon
3380
Business First Bancshares
BFST
$1.03B
$2K ﹤0.01%
80
-392
-83% -$9.43K
BNDX icon
3381
Vanguard Total International Bond ETF
BNDX
$83.1B
$2K ﹤0.01%
+35
New +$1.92K
BPMC
3382
DELISTED
Blueprint Medicines
BPMC
$2K ﹤0.01%
+26
New +$1.92K
BZQ icon
3383
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.51M
$2K ﹤0.01%
4
-1
-20% -$440
CACC icon
3384
Credit Acceptance
CACC
$6.08B
$2K ﹤0.01%
4
-408
-99% -$176K
CDNA icon
3385
CareDx
CDNA
$2.42B
$2K ﹤0.01%
+60
New +$1.75K
CMT icon
3386
Core Molding Technologies
CMT
$234M
$2K ﹤0.01%
356
+113
+47% +$895
CPIX icon
3387
Cumberland Pharmaceuticals
CPIX
$117M
$2K ﹤0.01%
337
+68
+25% +$394
CRVS icon
3388
Corvus Pharmaceuticals
CRVS
$1.17B
$2K ﹤0.01%
408
-10,402
-96% -$43.9K
CVBF icon
3389
CVB Financial
CVBF
$3.99B
$2K ﹤0.01%
94
+34
+57% +$746
CWBC
3390
Community West Bancshares
CWBC
$684M
$2K ﹤0.01%
90
-2,857
-97% -$56K
CWK icon
3391
Cushman & Wakefield Ltd
CWK
$3.25B
$2K ﹤0.01%
127
-23,233
-99% -$400K
DRH icon
3392
Diamondrock Hospitality Co
DRH
$2.56B
$2K ﹤0.01%
153
+53
+53% +$548
DTSS icon
3393
Datasea Intelligent Technology Ltd
DTSS
$8.2M
$2K ﹤0.01%
52
+45
+643% +$2.23K
DXF
3394
Eason Technology Ltd
DXF
$1.55M
0
AXIA.PR
3395
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$2K ﹤0.01%
303
+244
+414% +$1.89K
EDRY icon
3396
EuroDry
EDRY
$100M
$2K ﹤0.01%
+200
New +$1.6K
EMIF icon
3397
iShares Emerging Markets Infrastructure ETF
EMIF
$13.1M
$2K ﹤0.01%
64
+57
+814% +$1.67K
EMLC icon
3398
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.8B
$2K ﹤0.01%
50
-788
-94% -$26.7K
EPOL icon
3399
iShares MSCI Poland ETF
EPOL
$818M
$2K ﹤0.01%
100
ESNT icon
3400
Essent Group
ESNT
$6.33B
$2K ﹤0.01%
+52
New +$2.14K

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.